研究業績（原著と症例報告のみ） 2014年

原著論文
1.
The utility of urinary myo-inositol as a marker of glucose intolerance. Ikezaki H, Furusyo N, Okada K, Ihara T, Hayashi T, Ogawa E, Kainuma M, Murata M, Hayashi J. Diabetes Res Clin Pract 103: 88-96, 2014.
2.
Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection. Ogawa E, Furusyo N, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Nakamuta M, Satoh T, Azuma K, Kawano A, Tanabe Y, Kotoh K, Shimoda S, Hayashi J. Antiviral Res 104: 102-109, 2014.
3.
Efficacy and tolerance of interferon beta plus ribavirin treatment for chronic hepatitis C patients with depression or thrombocytopenia comparison with pegylated interferon alpha plus ribavirin treatment. Ikezaki H, Furusyo N, Ogawa E, Shimizu M, Hiramine S, Ura K, Mitsumoto F, Takayama K, Toyoda K, Murata M, Hayashi J. J Liver 3: 155, 2014.
4.
Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response. Furusyo N, Ogawa E, Murata M, Toyoda K, Ohnishi H, Eiraku K, Shimizu M, Harada Y, Mitsumoto F, Takayama K, Kainuma M, Okada K, Hayashi J. J Antimicrob Chemother 69: 483-490, 2014.
5.
Nocturnal difference in the ultra low frequency band of heart rate variability in patients stratified by Kampo medicine prescription. Kainuma M, Furusyo N, Ando S, Mukae H, Ogawa E, Toyoda K, Murata M, Hayashi J. Circ J 78: 1924-1927, 2014.
6.
Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis. Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A, Tanabe Y, Kotoh K, Shimoda S, Akahoshi T, Maehara Y, Hayashi J. J Gastroenterol Hepatol 29: 1728-1735, 2014.
7.
The association between serum undercarboxylated osteocalcin level and type-2 diabetes mellitus: Results from the Kyushu and Okinawa Population Study. Furusyo N, Ikezaki H, Hayashi T, Ihara T, Hiramine S, Mitsumoto F, Ura K, Takayama K, Toyoda T, Ogawa E, Kainuma M, Murata M, Hayashi J. J Clin Res Drug Dev 1: 2, 2014.
8.
Assessment of the reductions in night-time blood pressure and dipping induced by antihypertensive medication using a home blood pressure monitor. Ishikawa J, Shimizu M, Sugiyama Edison E, Yano Y, Hoshide S, Eguchi K, Kario K; J-TOP (Japan Morning Surge-Target Organ Protection) Study Investigators Group. J Hypertens 32: 82-89, 2014.
9.
Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C. Ikegami T, Wang H, Yoshizumi T, Toshima T, Aishima S, Fukuhara T, Furusyo N, Kotoh K, Shimoda S, Shirabe K, Maehara Y. Hepatol Int 8: 285-292, 2014.
10.
Filaggrin loss-of-function mutations are not a predisposing factor for atopic dermatitis in an Ishigaki Island under subtropical climate. Sasaki T, Furusyo N, Shiohama A, Takeuchi S, Nakahara T, Uchi H, Hirota T, Tamari M, Shimizu N, Ebihara T, Amagai M, Furue M, Hayashi J, Kudoh J. J Dermatol Sci 76: 10-15, 2014.
11.
ナノ型乳酸菌Enterococcus faecalis(nEC)含有ガムとグミ摂取によるヒトへの安全性および免疫調整作用に関する検討 村田昌之、古庄憲浩、柳澤昊永、林　純 臨牀と研究　91: 577-582, 2014.
12.
不明熱診療にPET/CTは必要か？?PET/CTが診断に寄与した症例をふまえて?． 酒見倫子、溝岡雅文、小林知貴、岸川暢介、横林賢一、菅野啓司、串畑重行、田妻　進 日本病院総合診療医学会雑誌　5: 49-55, 2014.


症例報告
1.
A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy. Murata M, Furusyo N, Ogawa E, Mitsumoto F, Hiramine S, Ikezaki H, Takayama K, Shimizu M, Toyoda K, Kainuma M, Hayashi J. J Infect Chemother 20: 320-324, 2014.
2.
A case of successful treatment with telaprevir-based triple therapy for hepatitis C infection after treatment failure with vaniprevir-based triple therapy. Takayama K, Furusyo N, Ogawa E, Shimizu M, Hiramine S, Mitsumoto F, Ura K, Toyoda K, Murata M, Hayashi J. J Infect Chemother 20: 577-581, 2014.
3.
Hepatitis B virus-related immune reconstitution inflammatory syndrome in two patients coinfected with human immunodeficiency virus diagnosed with a liver biopsy. Mitsumoto F, Murata M, Kato Y, Ura K, Takayama K, Hiramine S, Ikezaki H, Shimizu M, Toyoda K, Ogawa E, Aishima S, Furusyo N, Hayashi J. Intern Med 53: 2165-2170, 2014
4.
バセドウ病に対して甲状腺全摘術10年後に緩徐進行1型糖尿病を発症した多腺性自己免疫症候群Ⅲ型の1例 小森彩佳、岡田享子、大西八郎、小川栄一、豊田一弘、貝沼茂三郎、村田昌之、古庄憲浩、林　純 日本病院総合診療医学会雑誌 6(1): 16-19, 2014
5.
右上腕リンパ節膿瘍を形成し外科的処置を要した猫ひっかき病の一例 加藤禎史、古庄憲浩、志水元洋、小川栄一、山?　奨、迎　はる、豊田一弘、貝沼茂三郎、村田昌之、 林　純 日本病院総合診療医学会雑誌　6(1): 28-31, 2014
6.
市中感染型MRSAにより生じた化膿性脊椎炎の一例 志水元洋、村田昌之、光本富士子、迎　はる、小川栄一、豊田一弘、岡田享子、貝沼茂三郎、 江藤義隆、古庄憲浩、林　純 化学療法の領域 30: 805-811, 2014.

＜研究分野・研究実績トップへ戻る

ページの先頭へ移動する